Correlation Between Cochlear and Imugene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cochlear and Imugene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cochlear and Imugene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cochlear and Imugene, you can compare the effects of market volatilities on Cochlear and Imugene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cochlear with a short position of Imugene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cochlear and Imugene.

Diversification Opportunities for Cochlear and Imugene

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cochlear and Imugene is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Cochlear and Imugene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Imugene and Cochlear is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cochlear are associated (or correlated) with Imugene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Imugene has no effect on the direction of Cochlear i.e., Cochlear and Imugene go up and down completely randomly.

Pair Corralation between Cochlear and Imugene

Assuming the 90 days trading horizon Cochlear is expected to generate 0.27 times more return on investment than Imugene. However, Cochlear is 3.73 times less risky than Imugene. It trades about 0.07 of its potential returns per unit of risk. Imugene is currently generating about -0.02 per unit of risk. If you would invest  20,418  in Cochlear on November 2, 2024 and sell it today you would earn a total of  11,482  from holding Cochlear or generate 56.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cochlear  vs.  Imugene

 Performance 
       Timeline  
Cochlear 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Cochlear are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain technical indicators, Cochlear may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Imugene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Imugene has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cochlear and Imugene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cochlear and Imugene

The main advantage of trading using opposite Cochlear and Imugene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cochlear position performs unexpectedly, Imugene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imugene will offset losses from the drop in Imugene's long position.
The idea behind Cochlear and Imugene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Commodity Directory
Find actively traded commodities issued by global exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios